Gilead Sciences Executives Make Significant Trades Amid Market Volatility.

Gilead Sciences, Inc. [GILD] recently disclosed that Jeffrey Bluestone, a member of the company's board of directors, acquired 5,000 shares at a price of $64.92 per share on November 28, 2025, and subsequently sold an equivalent number of shares at $125.08 per share on the same day. Additionally, Kelly A. Kramer, another member of the board, purchased 2,806 shares at $81 per share on November 26, 2025, and then sold 2,805 shares at $127.10 per share on November 28, 2025, as well as 2,806 shares at $127.11 per share on the same day. Furthermore, Daniel Patrick O'Day, the company's director, chairman, and CEO, sold 3,212 shares at $125.91 per share on November 28, 2025, and an additional 6,788 shares at $126.84 per share on the same day. These transactions were reported in accordance with regulatory requirements.